CYP17A1 and coronary artery disorder: The presence of CpG islands was not detected, and the mutation was capable of contributing to the change of transcription factor binding sites (data not shown), which may affect the expression of CYP17A1 gene, the activity of related enzymes, and may be related to the pathogenesis of CAD.